Seneste forsøg


EudraCT Number: 2004-001281-40 Sponsor Protocol Number: 20040615 Start Date: 2004-09-23
Sponsor Name: Gottfries Clinic
Full Title: Long-term study with the staphylococcus vaccine Staphypan in treatment of patients with fibromyalgia and chronic fatigue syndrome
Medical condition: Fibromyalgia M79.0 + Chronic fatigue syndrome F48.0
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: SE (Ongoing)
Trial results: (No results available)

EudraCT Number: 2004-000954-22 Sponsor Protocol Number: CI-1008-100 Start Date: 2004-09-23
Sponsor Name: Pfizer Global Research & Development
Full Title: A 1-Year Open-Label Safety Extension Study of Pregabalin (CI-1008) in Patients With Anxiety Disorders
Medical condition: Generalized Anxiety Disorder
Disease: Version SOC Term Classification Code Term Level
Population Age: Elderly Gender: Male, Female
Trial protocol: LV (Completed)
Trial results: View results
EudraCT Number: 2004-001538-18 Sponsor Protocol Number: 603-PG-PSC-74 Start Date: 2004-09-23
Sponsor Name: LETI Pharma GmbH
Full Title: A randomised, double blinded, placebo controlled multicentre study for the efficacy and safety of Depigoid birch pollen
Medical condition: Patients have to suffer from IgE mediated allergic rhinits, rhinoconjunctivitis +/- asthma due to sensitization again birch pollen.
Disease: Version SOC Term Classification Code Term Level
7.0 10036019 LLT
Population Age: Children, Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: SE (Completed)
Trial results: View results

EudraCT Number: 2004-000424-32 Sponsor Protocol Number: 045 Start Date: 2004-09-23
Sponsor Name: Merck Sharp & Dohme BV
Full Title: A Multicenter, Open, Noncomparative Study to Estimate the Safety, Tolerability, and Efficacy of Caspofungin Acetate in the Treatment of Adults with Invasive Candida Infections (Excluding Patients w...
Medical condition: Non-Blood Invasive Candidiasis
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: BE (Completed)
Trial results: View results
EudraCT Number: 2004-000113-18 Sponsor Protocol Number: CLIC477D2302 Start Date: 2004-09-23
Sponsor Name: Novartis Farmacéutica, S.A.
Full Title: A randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy, safety and tolerability of licarbazepine 750-2500 mg/d combined with risperidone in the treatment of mani...
Medical condition: Bipolar I disorder, manic and mixed episodes
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: ES (Completed) HU (Completed) FI (Prematurely Ended)
Trial results: View results

EudraCT Number: 2004-001583-52 Sponsor Protocol Number: Intu Start Date: 2004-09-22
Sponsor Name: Lund University Hospital
Full Title: Balanced anestesia for intubation of newborn premature infants – a randomized intervention study Balanserad anestesi för intubation av nyfödda prematura barn – en randomiserad interventionsstudie
Medical condition: Respiratory insufficiency in prematrue infants requiring ventilatory assistance and therefore intubation. Premedication before intubation.
Disease: Version SOC Term Classification Code Term Level
Population Age: Preterm newborn infants, Newborns, Under 18 Gender: Male, Female
Trial protocol: SE (Completed)
Trial results: (No results available)
EudraCT Number: 2005-000393-47 Sponsor Protocol Number: SP000680 Start Date: 2004-09-22
Sponsor Name: AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA
Full Title: Effect of Cannabis Based Medicine Extract Sativex on brain function as assessed by fMRI and neurophysiologic evaluation in patients with Multiple Sclerosis a double blind, randomised, placebo-co...
Medical condition: Treatment of spasticity in patients with Multiple Sclerosis
Disease: Version SOC Term Classification Code Term Level
9.1 10028245 Multiple sclerosis LLT
Population Age: Adults Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: (No results available)

EudraCT Number: 2004-002125-42 Sponsor Protocol Number: CTH9507J Start Date: 2004-09-22
Sponsor Name: AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO"
Full Title: EFFECT OF PROLONGED TREATMENT WITH TH9507 ON IGF-I LEVELS IN ADOLESCENTS WITH ISOLATED GH DEFICIENCY DUE TO HYPOTHALAMIC PATHOGENESIS
Medical condition: EVALUATION OF GROWTH HORMONE RELEASE
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: IT (Ongoing)
Trial results: (No results available)
EudraCT Number: 2004-001967-24 Sponsor Protocol Number: L 9259 Start Date: 2004-09-22
Sponsor Name: Sanofi-Synthelabo Rt.
Full Title: Kiegészítő zolpidem kezelés friss antidepresszáns kezelés alatt álló disztimiás vagy depressziós betegek alvászavarának kezelésében
Medical condition: A depresszióban szenvedő betegek alvászavarára jellemzően megfigyelhető kóros alvásparaméterek lehetnek az elalvás nehezítettsége, töredezett, felszínes alvás gyakori felébredésekkel, az újra elalv...
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: HU (Completed)
Trial results: View results

EudraCT Number: 2004-001091-40 Sponsor Protocol Number: 2-47-52030-722 Start Date: 2004-09-22
Sponsor Name: Beaufour Ipsen Pharma
Full Title: A Phase III, Prospective, Multicentre, Randomised, Open, Parallel Group Comparison of Lanreotide Autogel (90 and 120mg) Administered by Deep Subcutaneous Injection Every Four Weeks, with Sandostati...
Medical condition: Treatment of clinical symptoms of carcinoid syndrome.
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: FI (Completed)
Trial results: View results
3
Abonner